Correlation Between Fate Therapeutics and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Neurocrine Biosciences, you can compare the effects of market volatilities on Fate Therapeutics and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Neurocrine Biosciences.
Diversification Opportunities for Fate Therapeutics and Neurocrine Biosciences
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Fate and Neurocrine is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Neurocrine Biosciences
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Neurocrine Biosciences. In addition to that, Fate Therapeutics is 5.84 times more volatile than Neurocrine Biosciences. It trades about -0.17 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.22 per unit of volatility. If you would invest 12,711 in Neurocrine Biosciences on September 24, 2024 and sell it today you would earn a total of 831.00 from holding Neurocrine Biosciences or generate 6.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Neurocrine Biosciences
Performance |
Timeline |
Fate Therapeutics |
Neurocrine Biosciences |
Fate Therapeutics and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Neurocrine Biosciences
The main advantage of trading using opposite Fate Therapeutics and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Neurocrine Biosciences vs. Fate Therapeutics | Neurocrine Biosciences vs. Sana Biotechnology | Neurocrine Biosciences vs. Caribou Biosciences | Neurocrine Biosciences vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |